{"cik":1778922,"taxonomy":"us-gaap","tag":"AllocatedShareBasedCompensationExpense","label":"Share-based Payment Arrangement, Expense","description":"Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.","entityName":"SpyGlass Pharma, Inc.","units":{"USD":[{"start":"2024-01-01","end":"2024-12-31","val":1500000,"accn":"0001778922-26-000020","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-26","frame":"CY2024"},{"start":"2025-01-01","end":"2025-03-31","val":300000,"accn":"0001778922-26-000035","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-14","frame":"CY2025Q1"},{"start":"2025-01-01","end":"2025-12-31","val":2800000,"accn":"0001778922-26-000020","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-26","frame":"CY2025"},{"start":"2026-01-01","end":"2026-03-31","val":1700000,"accn":"0001778922-26-000035","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-14","frame":"CY2026Q1"}]}}